Literature DB >> 1422680

Acquired cystic disease of the kidney and renal carcinoma in haemodialysis patients: ultrasonographic evaluation.

I Sasagawa1, Y Terasawa, K Imai, H Sekino, H Takahashi.   

Abstract

Ultrasonography was performed in 661 dialysis patients and acquired cystic disease of the kidney was found in 156 (125 men and 31 women). A higher incidence of cystic disease was found in males. There was no significant difference between the patients with and those without acquired cystic disease in terms of average age, but the duration of haemodialysis in those with acquired cystic disease was significantly longer. There was an increased incidence of cystic disease in patients with glomerulonephritis and the duration of haemodialysis in these patients was significantly longer. This suggests that the increased incidence of acquired cystic disease of the kidneys in the patients with glomerulonephritis is simply related to the longer duration of treatment. Twelve patients with renal carcinoma were found in this study. The average age at diagnosis of renal carcinoma was not significantly different between the patients with and those without acquired cystic disease, but the duration of dialysis was significantly longer in renal carcinoma patients with acquired cystic disease. The incidence of renal carcinoma in dialysis patients with acquired cystic disease was 3.85% and in those without it was 1.19%. These rates are considerably higher than those found in the general population and indicate that the risk of renal carcinoma is higher in dialysis patients both with and without acquired cystic disease.

Entities:  

Mesh:

Year:  1992        PMID: 1422680     DOI: 10.1111/j.1464-410x.1992.tb15723.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  3 in total

1.  Acquired cystic kidney disease and arterial hypertension in hemodialysis patients.

Authors:  Robert Ekart; Radovan Hojs
Journal:  Wien Klin Wochenschr       Date:  2006       Impact factor: 1.704

2.  Bladder cancer in a patient on long-term haemodialysis.

Authors:  H Hadatsuki; I Sasagawa; H Suzuki; H Yaguchi; A Mutoh; Y Kubota; T Nakada
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

3.  Serum immunosuppressive acidic protein in haemodialysis patients with and without acquired cystic disease of the kidney.

Authors:  I Sasagawa; T Nakada; Y Kubota; T Sawamura
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.